G

G1 Therapeutics

D
GTHX
USD
0.01
(0.1399%)
Market Closed
30,342.00
Volume
-0.56
EPS
-
Div Yield
-8.325581
P/E
377,748,647.56
Market Cap
Today
0.1399%
1 Week
0.491%
1 Month
0.703%
6 Months
130.968%
12 Months
364.935%
Year To Date
134.754%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news

Thailand's Economy Stumbles as Regional Peers Improve

04.04.2024
Economy news
More
Related Instruments
MRK
MRK
-1.44
(-1.2137%)
USD
BMY
BMY
-0.72
(-1.4475%)
USD
PFE
PFE
-0.09
(-0.3025%)
USD
ABBV
ABBV
0.73
(0.3784%)
USD
NVS
NVS
-0.02
(-0.0172%)
USD
JNJ
JNJ
-1.31
(-0.7883%)
USD
LLY
LLY
10.49
(1.1589%)
USD
GSK
GSK
-0.78
(-1.8383%)
USD
AZN
AZN
0.32
(0.4072%)
USD

Title:
G1 Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat the types of cancer, such as cell lung cancer and breast cancer, and designs them to combine and enhance the anti-tumor activity of current therapies. Its product COSELA indicates to help protect bone marrow from the damage of chemotherapy.
Do you need help or have a question?
Contact Us